BioNexus Gene Lab Corp. (BGLC)
0.25
-0.05 (-16.44%)
At close: Mar 28, 2025, 2:20 PM
Company Description
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn.
Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia.
Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments.
The company, through its subsidiary, BioNexus Gene Lab Sdn.
Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers.
The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
BioNexus Gene Lab Corp.
| Country | MY |
| IPO Date | Jan 8, 2021 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 30 |
| CEO | Su-Leng Tan |
Contact Details
Address: Tower B, Vertical Business Suite Kuala Lumpur, MY | |
| Website | https://www.bionexusgenelab.com |
Stock Details
| Ticker Symbol | BGLC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001737523 |
| CUSIP Number | 090628108 |
| ISIN Number | US0906282076 |
| Employer ID | 26-2124961 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Su-Leng Tan | Chief Executive Officer, Acting Chief Financial Officer, Secretary & Director |
| Kwan Wah Chan | Marketing Manager |
| Too Kam Tham | Managing Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 25, 2025 | 8-K | Current Report |
| Mar 07, 2025 | 8-K | Current Report |
| Mar 05, 2025 | 8-K | Current Report |
| Feb 28, 2025 | DEFR14A | Filing |
| Feb 27, 2025 | DEF 14A | Filing |
| Feb 14, 2025 | 8-K | Current Report |
| Feb 10, 2025 | PRE 14A | Filing |
| Jan 02, 2025 | 8-K | Current Report |
| Nov 15, 2024 | 10-Q | Quarterly Report |
| Nov 14, 2024 | NT 10-Q | Filing |